Basic information Safety Supplier Related

[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT

Basic information Safety Supplier Related

[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT Basic information

Product Name:
[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT
Synonyms:
  • H-HIS-SER-ASP-ALA-VAL-D-PHE(4-CL)-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-LEU-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2
  • HIS-SER-ASP-ALA-VAL-PCL-D-PHE-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-LEU-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2
  • (D-PHE(4-CL)6,LEU17)-VIP (HUMAN,BOVINE, PORCINE, RAT)
  • [D-P-CL-PHE6,LEU17]-VASOACTIVE INTESTINAL PEPTIDE
  • [D-P-CL-PHE6,LEU17]-VASOACTIVE INTESTINAL PEPTIDE HUMAN
  • [D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT
  • (D-P-CL-PHE6,LEU17)-VASOACTIVE*INTESTINA L PEPTIDE H
  • [d-p-cl-phe6,leu17]-vasoactiveintestinalpeptidefromprocine
CAS:
102805-45-8
MF:
C148H239ClN44O42
MW:
3342.2
Mol File:
102805-45-8.mol
More
Less

[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT Chemical Properties

Density 
1.47±0.1 g/cm3(Predicted)
storage temp. 
-20°C
form 
Powder
Water Solubility 
Soluble to 1 mg/ml in water
Sequence
His-Ser-Asp-Ala-Val-{Cl-Phe}-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Leu-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2
More
Less

Safety Information

WGK Germany 
3

MSDS

More
Less

[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT Usage And Synthesis

Uses

[D-p-Cl-Phe6,Leu17]-VIP is a competitive and selective antagonist of vasoactive intestinal peptide (VIP) receptor, with the IC50 of 125.8 nM. [D-p-Cl-Phe6,Leu17]-VIP has no activity on glucagon, secretin or GRF receptors[1][2][3].

Biochem/physiol Actions

VIP receptor antagonist

storage

Store at -20°C

References

[1] Pozo D, et, al. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages. Eur J Pharmacol. 1997 Mar 5; 321(3): 379-86. DOI:10.1016/s0014-2999(96)00966-1
[2] Pandol SJ, et, al. Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP. Am J Physiol. 1986 Apr; 250 (4 Pt 1): G553-7. DOI:10.1152/ajpgi.1986.250.4.G553
[3] Messmer B, et, al. Regulation of exocrine pancreatic secretion by cerebral TRH and CGRP: role of VIP, muscarinic, and adrenergic pathways. Am J Physiol. 1993 Feb; 264(2 Pt 1): G237-42. DOI:10.1152/ajpgi.1993.264.2.G237

[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RATSupplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Email
ymbetter@glbiochem.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Hunan Hui Bai Shi Biotechnology Co., Ltd.
Tel
0731-85526065 13308475853
Email
ivy@hnhbsj.com